David Schneider

Title: The Innovative Contributions of David Schneider

Introduction

David Schneider is a notable inventor based in Shelburne, Vermont. He has made significant contributions to the field of medical technology, particularly in the area of platelet aggregation and reactivity. With a total of two patents to his name, Schneider's work has the potential to impact patient care and treatment protocols.

Latest Patents

Schneider's latest patents include a method for inhibiting platelet aggregation and a method for determining platelet reactivity in a whole blood sample. The first patent describes a method for inhibiting platelet aggregation in patients by administering a bolus injection of an active drug, followed by an intravenous infusion over a specified period. The active drug mentioned is tirofiban or a salt thereof. The second patent provides a method for quantifying and assessing platelet activation in whole blood samples, which involves exposing platelets to a physiological concentration of an agonist. This method allows for the monitoring of antiplatelet pharmacologic agents and the assessment of specific components of platelet activation.

Career Highlights

Throughout his career, David Schneider has worked with various companies, including Lionheart Technologies, Inc. and Artery LLC. His experience in these organizations has contributed to his expertise in medical innovations and the development of new technologies aimed at improving patient outcomes.

Collaborations

Schneider has collaborated with notable professionals in his field, including Burton E. Sobel and Paula